A recent study provides strong economic arguments about the true costs of tuberculosis and the benefits of increasing funding to combat it, according to the WHO.
Substantial patient safety gaps regarding latent tuberculosis screening persist among new users of biologic or targeted synthetic DMARDs, suggested a nationwide cohort study.
World TB Day: Making these lifestyle adjustments can significantly reduce the risk of tuberculosis transmission within families and among close contacts.
Review found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment.